In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
researchers have developed a method for in vivo generation of CAR myeloid cells using erythrocyte-mediated mRNA delivery. this approach is being explored for its potential in cancer immunotherapy. the method involves using red blood cells to deliver mRNA and generate CAR myeloid cells in the body.